1. A review of neurotoxicities associated with immunotherapy and a framework for evaluation. (27th November 2021) Authors: Burton, Leeann B; Eskian, Mahsa; Guidon, Amanda C; Reynolds, Kerry L Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 5 Page Start: v108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Basic understanding and therapeutic approaches to target toll‐like receptors in cancerous microenvironment and metastasis. Issue 5 (28th December 2017) Authors: Khajeh Alizadeh Attar, Mojtaba; Anwar, Muhammad Ayaz; Eskian, Mahsa; Keshavarz‐Fathi, Mahsa; Choi, Sangdun; Rezaei, Nima Journal: Medicinal research reviews Issue: Volume 38:Issue 5(2018) Page Start: 1469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma. (3rd July 2016) Authors: Khorasanizadeh, MirHojjat; Eskian, Mahsa; Assa'ad, Amal H.; Camargo Jr., Carlos A.; Rezaei, Nima Journal: International reviews of immunology Issue: Volume 35:Number 4(2016:Aug.) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immune checkpoint inhibition in classical hodgkin lymphoma. Issue 9 (2nd September 2021) Authors: Pezeshki, Parmida Sadat; Eskian, Mahsa; Hamblin, Michael R; Rezaei, Nima Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 9(2021) Page Start: 1003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma. (4th March 2019) Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Zinzani, Pier Luigi; Illidge, Tim M.; Rezaei, Nima Journal: International reviews of immunology Issue: Volume 38:Number 2(2019) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. (23rd March 2018) Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Zinzani, Pier L; Rezaei, Nima Journal: Immunotherapy Issue: Volume 10:Number 8(2018) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response. (November 2016) Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Kraeber-Bodere, Francoise; Rezaei, Nima Journal: Critical reviews in oncology/hematology Issue: Volume 107(2016) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response. (November 2016) Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Kraeber-Bodere, Francoise; Rezaei, Nima Journal: Critical reviews in oncology/hematology Issue: Volume 107(2016) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma. (13th June 2018) Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Isidori, Alessandro; Rezaei, Nima Journal: International journal of hematologic oncology Issue: Volume 7:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Representing narrative evidence as clinical evidence logic statements. Issue 2 (11th April 2022) Authors: Lacson, Ronilda; Eskian, Mahsa; Cochon, Laila; Gujrathi, Isha; Licaros, Andro; Zhao, Anna; Vetrano, Nicole; Schneider, Louise; Raja, Ali; Khorasani, Ramin Journal: JAMIA open Issue: Volume 5:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗